Stockscreener 앱 받기
236.66
4.49%
-11.12
전일 마감가:
$247.78
열려 있는:
$246
하루 거래량:
1.93M
Relative Volume:
2.49
시가총액:
$17.03B
수익:
$2.96B
순이익/손실:
$487.70M
주가수익비율:
35.45
EPS:
6.6758
순현금흐름:
$344.00M
1주 성능:
-8.90%
1개월 성능:
-14.71%
6개월 성능:
+4.11%
1년 성능:
-31.20%
1일 변동 폭
$232.06
$246.13
1주일 범위
$232.06
$258.74
52주 변동 폭
$187.43
$348.90
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
236.66 | 17.83B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
523.99 | 186.40B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
201.79 | 58.70B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.29 | 39.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
46.00 | 38.25B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
252.38 | 37.27B | 5.26B | 1.44B | 1.76B | 9.7713 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West to Sell SmartDose 3.5mL System to AbbVie in $112.5M Deal - mychesco.com
Reasons to add West Pharmaceutical stock to your portfolio now - MSN
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MSN
Market Wrap: Can West Pharmaceutical Services Inc grow without dilutionJuly 2025 Sentiment & Daily Profit Maximizing Tips - baoquankhu1.vn
Is West Pharmaceutical Services Stock Built to Withstand More Downside? - Trefis
West Pharmaceutical Sells SmartDose Rights To AbbVie And Refocuses Portfolio - Sahm
Analysis Recap: Can AROW grow without external funding2025 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - baoquankhu1.vn
WST Launches Synchrony S1 Prefillable Syringe at Pharmapack - sharewise.com
West Pharmaceutical Services Becomes Oversold (WST) - Nasdaq
Bull Run: Is West Pharmaceutical Services Inc trading at a discountM&A Rumor & Weekly Momentum Picks - baoquankhu1.vn
West Pharmaceutical Services (NYSE:WST) Stock Rating Upgraded by Zacks Research - MarketBeat
Zacks Research Issues Optimistic Estimate for WST Earnings - MarketBeat
Does West Pharmaceutical (WST) Expanding Into Biologic Syringe Systems Reshape Its Combination-Product Edge? - Yahoo Finance
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology - The Globe and Mail
Market Outlook: Is West Pharmaceutical Services Inc stock showing strong momentumEntry Point & Precise Swing Trade Alerts - baoquankhu1.vn
Performance Recap: Whats the outlook for West Pharmaceutical Services Incs sector2025 Historical Comparison & Fast Entry High Yield Tips - baoquankhu1.vn
After Plunging 9.7% in 4 Weeks, Here's Why the Trend Might Reverse for West Pharmaceutical (WST) - yourwyominglink.com
All You Need to Know About West Pharmaceutical (WST) Rating Upgrade to Strong Buy - Yahoo Finance
West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day - 富途资讯
Is West Pharmaceutical (WST) Quietly Redefining Its Edge Through Integrated Drug‑Device Innovation? - Sahm
Vest Financial LLC Sells 48,353 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Rakuten Investment Management Inc. Takes $24.68 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
United States Vaccine Packaging Market to hit US$ 870 Million - openPR.com
West launches prefillable syringe system at Pharmapack 2026 By Investing.com - Investing.com Australia
West launches prefillable syringe system at Pharmapack 2026 - Investing.com
West Pharmaceutical Launches New Prefillable Syringe System to Enhance Drug Delivery - Intellectia AI
New prefilled syringe system targets biologic and vaccine delivery - Stock Titan
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
Upslope Capital Management Exited West Pharmaceutical (WST) for Better Opportunities - Yahoo Finance
Aug Breakouts: Is West Pharmaceutical Services Inc stock showing strong momentumJuly 2025 Outlook & Verified Chart Pattern Trade Signals - baoquankhu1.vn
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
West Pharmaceutical Services (NYSE:WST) Stock Price Down 5.1%What's Next? - MarketBeat
West Pharmaceutical Services Inc (WST) Stock Price Down 4.85% on Jan 16 - GuruFocus
West Pharmaceutical Services, Inc. $WST Shares Sold by EULAV Asset Management - MarketBeat
AbbVie to buy Arizona manufacturing facility from West Pharmaceutical - MSN
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Earnings Preview: What to Expect From West Pharmaceutical Services' Report - Barchart.com
Is West Pharmaceutical Services (WST) Pricing Look Stretched After Recent Share Price Weakness - Sahm
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Finviz
Gov. Braun accelerates life sciences leadership with more than 1,300 new high wage jobs across the state - WBIW
Is It Time To Reassess West Pharmaceutical Services (WST) After Its Recent Share Price Slide - Yahoo Finance
AbbVie To Buy Device Manufacturing Facility From West Pharmaceutical Services - Med Device Online
Wall Street Analysts See a 26.42% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High? - sharewise.com
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines - Benzinga
AbbVie adds Arizona plant to $10bn US manufacturing push - The Pharma Letter
Chicago's AbbVie to acquire Tempe medical device manufacturing facility - The Business Journals
Key facts: AbbVie partners with RemeGen; acquires West Pharma rights - TradingView — Track All Markets
Strategy To YieldBoost West Pharmaceutical Services From 0.3% To 5.2% Using Options - Nasdaq
AbbVie Inc. (NYSE : ABBV) entered into a definitive agreement to acquire Device manufacturing facility in Tempe, Arizona from West Pharmaceutical Services, Inc. (NYSE - marketscreener.com
West Pharmaceutical Selling SmartDose 3.5mL On-Body Delivery System Manufacturing Rights To AbbVie For $112.5 Million - Pulse 2.0
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines - Sahm
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
자본화:
|
볼륨(24시간):